We are live on ! Find out more
MED icon

Medifast

165 hedge funds and large institutions have $390M invested in Medifast in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 52 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,180% more call options, than puts

Call options by funds: $1.17M | Put options by funds: $91K

71% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 17

15% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 52

13% more capital invested

Capital invested by funds: $344M → $390M (+$45.8M)

8% more funds holding

Funds holding: 153165 (+12)

0.84% more ownership

Funds ownership: 87.29%88.13% (+0.84%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
165
Holders Change
+12
Holders Change %
+7.84%
% of All Funds
4.4%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
60
Reduced
52
Closed
17
Calls
$1.17M
Puts
$91K
Net Calls
+$1.07M
Net Calls Change
-$89K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$3.1M +$569K +15,874 +24%
DIA
27
Dean Investment Associates
Ohio
$3.06M +$2.61M +72,693 +893%
Two Sigma Investments
28
Two Sigma Investments
New York
$3.04M -$4.69M -130,851 -62%
CAM
29
ClariVest Asset Management
California
$2.98M -$37K -1,032 -1%
QI
30
QS Investors
New York
$2.9M +$173K +4,820 +7%
Morgan Stanley
31
Morgan Stanley
New York
$2.76M -$2.71M -75,478 -51%
EA
32
Emerald Acquisition
Washington
$2.68M +$723K +20,164 +40%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$2.6M -$201K -5,600 -8%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$2.6M -$1.29M -36,033 -34%
ISL
35
Ingalls & Snyder LLC
New York
$2.6M -$79.8K -2,225 -3%
Ameriprise
36
Ameriprise
Minnesota
$2.57M +$361K +10,060 +17%
Federated Hermes
37
Federated Hermes
Pennsylvania
$2.47M -$326K -9,087 -12%
MAM
38
Martingale Asset Management
Massachusetts
$2.17M +$1.57M +43,900 +323%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$2.16M -$3.54M -98,697 -63%
CCM
40
Chickasaw Capital Management
Tennessee
$2.14M
FQ
41
First Quadrant
California
$1.97M +$1.17M +32,604 +167%
BIM
42
BlackRock Investment Management
Delaware
$1.77M +$22.7K +633 +1%
PPA
43
Parametric Portfolio Associates
Washington
$1.75M -$129K -3,604 -7%
Wellington Management Group
44
Wellington Management Group
Massachusetts
$1.74M
Wells Fargo
45
Wells Fargo
California
$1.61M +$145K +4,037 +10%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$1.54M -$232K -6,463 -14%
SFM
47
Systematic Financial Management
New Jersey
$1.53M -$556K -15,510 -28%
Goldman Sachs
48
Goldman Sachs
New York
$1.51M -$1.75M -48,699 -55%
TC
49
TFS Capital
Pennsylvania
$1.46M +$115K +3,220 +9%
Charles Schwab
50
Charles Schwab
California
$1.46M +$58.9K +1,642 +4%

MED Hedge Fund Activity: Q3 2016 in Review

165 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2016, worth a combined $390M — up 13% from $344M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new MED positions and 17 closed out — a net gain of 12 holders — while 60 added to existing stakes and 52 trimmed.

The largest buyer was McKinley Capital Management, opening a new position worth an estimated $5.12M. The largest seller was Two Sigma Investments, cutting an estimated $4.69M.

  • 165 institutional investors held Medifast (MED) as of Q3 2016, up from 153 in Q2 2016.
  • Funds reported $390M of Medifast stock for Q3 2016, up 13% quarter-over-quarter.
  • 29 funds opened new Medifast positions in Q3 2016 and 17 closed out, a net change of +12 holders.
  • The largest Medifast buyer in Q3 2016 was McKinley Capital Management, an estimated $5.12M added.
  • The largest Medifast seller in Q3 2016 was Two Sigma Investments, an estimated $4.69M sold.

Based on aggregated 13F filings for Q3 2016.